142 related articles for article (PubMed ID: 17982680)
1. Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors.
Stapnes C; Ryningen A; Hatfield K; Øyan AM; Eide GE; Corbascio M; Kalland KH; Gjertsen BT; Bruserud Ø
Int J Oncol; 2007 Dec; 31(6):1529-38. PubMed ID: 17982680
[TBL] [Abstract][Full Text] [Related]
2. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
Qi H; Ratnam M
Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
[TBL] [Abstract][Full Text] [Related]
3. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells.
Morita K; Gotohda T; Arimochi H; Lee MS; Her S
J Neurosci Res; 2009 Aug; 87(11):2608-14. PubMed ID: 19360904
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
Mahlknecht U; Schönbein C
Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells.
Koyama N; Koschmieder S; Tyagi S; Nürnberger H; Wagner S; Böcker U; Hoelzer D; Gerhard Ottmann O; Kalina U
Biochem Biophys Res Commun; 2002 Apr; 292(4):937-43. PubMed ID: 11944905
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells.
Wu Y; Guo SW
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):198-203. PubMed ID: 17376583
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts.
Yasukawa K; Sawamura D; Goto M; Nakamura H; Shimizu H
Br J Dermatol; 2007 Oct; 157(4):662-9. PubMed ID: 17711521
[TBL] [Abstract][Full Text] [Related]
9. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
Kircher B; Schumacher P; Petzer A; Hoflehner E; Haun M; Wolf AM; Nachbaur D; Gastl G
Eur J Haematol; 2009 Jul; 83(1):48-56. PubMed ID: 19226363
[TBL] [Abstract][Full Text] [Related]
10. Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting.
Ryningen A; Stapnes C; Bruserud Ø
Leuk Res; 2007 Sep; 31(9):1303-13. PubMed ID: 17416413
[TBL] [Abstract][Full Text] [Related]
11. Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells.
Nakamura C; Matsushita I; Kosaka E; Kondo T; Kimura T
Rheumatology (Oxford); 2008 Apr; 47(4):418-24. PubMed ID: 18281366
[TBL] [Abstract][Full Text] [Related]
12. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.
Bradbury CA; Khanim FL; Hayden R; Bunce CM; White DA; Drayson MT; Craddock C; Turner BM
Leukemia; 2005 Oct; 19(10):1751-9. PubMed ID: 16121216
[TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo.
Tumber A; Collins LS; Petersen KD; Thougaard A; Christiansen SJ; Dejligbjerg M; Jensen PB; Sehested M; Ritchie JW
Cancer Chemother Pharmacol; 2007 Jul; 60(2):275-83. PubMed ID: 17124594
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins.
Bordin M; D'Atri F; Guillemot L; Citi S
Mol Cancer Res; 2004 Dec; 2(12):692-701. PubMed ID: 15634758
[TBL] [Abstract][Full Text] [Related]
16. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.
Kim B; Rincón Castro LM; Jawed S; Niles LP
Eur J Pharmacol; 2008 Jul; 589(1-3):45-8. PubMed ID: 18550052
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor inhibits p38-mediated cell differentiation and growth inhibition by activin A but not by histone deacetylase inhibitors in CML cells.
Chen CH; Lin JY; Liu FH; Chang JL; Huang HM
Ann Hematol; 2008 Mar; 87(3):175-82. PubMed ID: 17929017
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine is an inhibitor of histone deacetylases.
Beutler AS; Li S; Nicol R; Walsh MJ
Life Sci; 2005 May; 76(26):3107-15. PubMed ID: 15850602
[TBL] [Abstract][Full Text] [Related]
19. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
[TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.
Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD
Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
